CoChat

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus

Open access
Sanchez-Varo, Raquel, Trujillo-Estrada, Laura, Sanchez-Mejias, Elisabeth, Torres, Manuel, Baglietto-Vargas, David, Moreno-Gonzalez, Ines, De Castro, Vanessa, Jimenez, Sebastian, Ruano, Diego, Vizuete, Marisa, Davila, Jose Carlos, Garcia-Verdugo, Jose Manuel, Jimenez, Antonio Jesus, Vitorica, Javier, Gutierrez, Antonia · 2012 · Acta Neuropathologica

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer's disease (AD). In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old) PS1(M146L)/APP(751SL) mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the axonal dystrophies, and by electron microscopic identification of numerous autophagic vesicles filling and causing the axonal swellings. Early neuritic cytoskeletal defects determined by the presence of phosphorylated tau (AT8-positive) and actin-cofilin rods along with decreased levels of kinesin-1 and dynein motor proteins could be responsible for this extensive vesicle accumulation within dystrophic neurites. Although microsomal Aβ oligomers were identified, the presence of A11-immunopositive Aβ plaques also suggested a direct role of plaque-associated Aβ oligomers in defective axonal transport and disease progression. Most importantly, presynaptic terminals morphologically disrupted by abnormal autophagic vesicle buildup were identified ultrastructurally and further supported by synaptosome isolation. Finally, these early abnormalities in axonal and presynaptic structures might represent the morphological substrate of hippocampal dysfunction preceding synaptic and neuronal loss and could significantly contribute to AD pathology in the preclinical stages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-011-0896-x

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Early plaque-associated neuritic dystrophy pathology in PS1/APP hippocampus. a and b APP-immunolabeled sections counterstained with Congo red for fibrillar amyloid deposits at 4 (a) and 6 (b) months of age showing the early occurrence of the neuritic pathology. The number of neuritic plaques progressively increases with age. APP-positive dystrophic neurites arise from glutamatergic neurons since the human APP transgene is exclusively expressed by principal neurons as shown in the inset. c A representative neuritic plaque formed by a core of congophilic fibrillar amyloid surrounded by numerous APP-positive dystrophic neurites. d Confocal image showing APP-positive dystrophic neurites (red) around a plaque stained with thioflavin-S (green). e Stereological quantification of the dystrophic neurites around plaques. The number of dystrophies/plaque increased with the size of plaque (μm2). Data are expressed as mean ± SD, *p < 0.05. Scale bars a and b 500 μm, inset 25 μm, c and d 10 μm. CA1–CA3 subfields of the hippocampus proper, DG dentate gyrus
Fig. 1 Early plaque-associated neuritic dystrophy pathology in PS1/APP hippocampus. a and b APP-immunolabeled sections counterstained with Congo red for fibrillar amyloid deposits at 4 (a) and 6 (b) months of age showing the early occurrence of the neuritic pathology. The number of neuritic plaques progressively increases with age. APP-positive dystrophic neurites arise from glutamatergic neurons since the human APP transgene is exclusively expressed by principal neurons as shown in the inset. c A representative neuritic plaque formed by a core of congophilic fibrillar amyloid surrounded by numerous APP-positive dystrophic neurites. d Confocal image showing APP-positive dystrophic neurites (red) around a plaque stained with thioflavin-S (green). e Stereological quantification of the dystrophic neurites around plaques. The number of dystrophies/plaque increased with the size of plaque (μm2). Data are expressed as mean ± SD, *p < 0.05. Scale bars a and b 500 μm, inset 25 μm, c and d 10 μm. CA1–CA3 subfields of the hippocampus proper, DG dentate gyrusCC BY-NC · PubMed Central
Fig. 2 Extensive accumulation of autophagic vesicles within dystrophic neurites around amyloid plaques. Transmission electron microscopy images of plaque-associated aberrant neurites in young PS1/APP hippocampus. a Low magnification image of an amyloid plaque (asterisk) surrounded by dystrophic neurites (discontinuous white circles). b A diversity of dystrophic neurites based on their subcellular content can be identified. c and d Dystrophic neurite filled with heterogeneous electrodense double-membrane vesicles (white square magnified in d) belonging to the early degrading autophagy-lysosomal pathway (autophagosomes); these AVs had a dense compacted amorphous (filled white arrows) or multilamellar content (empty white arrows). e and f Dystrophic neurite filled with autophagic vesicles (white square magnified in f) of distinct morphologies showing translucent (filled white arrows) or amorphous electrodense material (empty white arrows) which might represent late autophagic vesicles (autophagolysosomes). Scale bars a 10 μm, b 2 μm, c and e 1 μm, d and f 500 nm
Fig. 2 Extensive accumulation of autophagic vesicles within dystrophic neurites around amyloid plaques. Transmission electron microscopy images of plaque-associated aberrant neurites in young PS1/APP hippocampus. a Low magnification image of an amyloid plaque (asterisk) surrounded by dystrophic neurites (discontinuous white circles). b A diversity of dystrophic neurites based on their subcellular content can be identified. c and d Dystrophic neurite filled with heterogeneous electrodense double-membrane vesicles (white square magnified in d) belonging to the early degrading autophagy-lysosomal pathway (autophagosomes); these AVs had a dense compacted amorphous (filled white arrows) or multilamellar content (empty white arrows). e and f Dystrophic neurite filled with autophagic vesicles (white square magnified in f) of distinct morphologies showing translucent (filled white arrows) or amorphous electrodense material (empty white arrows) which might represent late autophagic vesicles (autophagolysosomes). Scale bars a 10 μm, b 2 μm, c and e 1 μm, d and f 500 nmCC BY-NC · PubMed Central
Fig. 3 Autophagic compartments within dystrophic neurites are sites of APP processing. a and b Immunohistochemistry for the autophagosome marker LC3 in CA1 subfield of PS1/APP mice hippocampus. At 4 months (a), immunoreactivity was concentrated in pyramidal cell somata (stratum pyramidale) and their apical dendrites (stratum radiatum). LC3-positive dystrophic neurites were surrounded amyloid plaques (upper inset in a) and were punctate in nature (the lower inset shows a high magnification image of the LC3-positive dystrophy circled in the upper inset). At 6 months (b), the immunoreaction was mainly associated with dystrophic neurites around plaques (arrows) as shown here for stratum oriens (SO). c Quantitative immunoblot analysis of LC3-II form in the hippocampus of 6-month-old PS1/APP and WT mice. PS1/APP mice had significantly higher LC3-II levels than age-matched WT mice (n = 6, p < 0.05). d1–d3 Confocal images of double immunofluorescence labeling for APP (green) and LC3 (red); APP-positive dystrophic neurites around an amyloid plaque (asterisk) displayed the LC3 marker (long arrows); some LC3-positive dystrophic neurites were negative for APP (short arrows) indicating the non-glutamatergic origin of these aberrant neurites. e Dystrophic neurites (encircled) around amyloid plaques (asterisk) were APP immunopositive as revealed by electron microscopy using silver-enhanced immunogold labeling. f Higher magnification of a dystrophic neurite immunopositive for APP; small open squares indicate mitochondria; inset shows two autophagosomes immunogold-labeled for APP. g Higher magnification image of two autophagic vesicles immunogold-labeled for APP. h In addition to autophagic vesicles, APP immunogold labeling was associated with the endoplasmic reticulum (ER) and Golgi cisternae in neuronal somata. i Immunogold labeling revealed that Aβ42 peptides localize to amyloid plaques (asterisk) and autophagic vesicles (inset). so stratum oriens, sp stratum pyramidale, sr stratum radiatum. Scale bars a and b 100 μm (upper inset in a 50 μm, lower inset in a 10 μm); d1–d3 100 μm (inset in d2 2.5 μm), e–h 500 nm, inset in f 200 nm, i 2 μm and inset 400 nm
Fig. 3 Autophagic compartments within dystrophic neurites are sites of APP processing. a and b Immunohistochemistry for the autophagosome marker LC3 in CA1 subfield of PS1/APP mice hippocampus. At 4 months (a), immunoreactivity was concentrated in pyramidal cell somata (stratum pyramidale) and their apical dendrites (stratum radiatum). LC3-positive dystrophic neurites were surrounded amyloid plaques (upper inset in a) and were punctate in nature (the lower inset shows a high magnification image of the LC3-positive dystrophy circled in the upper inset). At 6 months (b), the immunoreaction was mainly associated with dystrophic neurites around plaques (arrows) as shown here for stratum oriens (SO). c Quantitative immunoblot analysis of LC3-II form in the hippocampus of 6-month-old PS1/APP and WT mice. PS1/APP mice had significantly higher LC3-II levels than age-matched WT mice (n = 6, p < 0.05). d1–d3 Confocal images of double immunofluorescence labeling for APP (green) and LC3 (red); APP-positive dystrophic neurites around an amyloid plaque (asterisk) displayed the LC3 marker (long arrows); some LC3-positive dystrophic neurites were negative for APP (short arrows) indicating the non-glutamatergic origin of these aberrant neurites. e Dystrophic neurites (encircled) around amyloid plaques (asterisk) were APP immunopositive as revealed by electron microscopy using silver-enhanced immunogold labeling. f Higher magnification of a dystrophic neurite immunopositive for APP; small open squares indicate mitochondria; inset shows two autophagosomes immunogold-labeled for APP. g Higher magnification image of two autophagic vesicles immunogold-labeled for APP. h In addition to autophagic vesicles, APP immunogold labeling was associated with the endoplasmic reticulum (ER) and Golgi cisternae in neuronal somata. i Immunogold labeling revealed that Aβ42 peptides localize to amyloid plaques (asterisk) and autophagic vesicles (inset). so stratum oriens, sp stratum pyramidale, sr stratum radiatum. Scale bars a and b 100 μm (upper inset in a 50 μm, lower inset in a 10 μm); d1–d3 100 μm (inset in d2 2.5 μm), e–h 500 nm, inset in f 200 nm, i 2 μm and inset 400 nmCC BY-NC · PubMed Central
Fig. 4 Dystrophic neurites are of axonal origin. a MAP-2 (dendritic marker) and Congo red staining in the hippocampus of 6-month-old PS1/APP mice (arrows indicate amyloid plaques). b No dystrophic neurites immunopositive for MAP-2 were seen around amyloid plaques, as illustrated here for a Congo red stained amyloid plaque (asterisk) embedded in a MAP2-positive neuropil in the radiatum layer. c1–c3 Confocal double immunofluorescence labeling for MAP-2 (red) and APP (green) revealed no colocalization of the two markers (asterisk indicates an amyloid plaque). d Strong overlapping in the location of hippocampal axonal pathways and amyloid plaques as shown here using neurofilament (NF) immunolabeling and Congo red staining. Axonal dystrophies were observed around congophilic plaques as shown in the larger inset, and a detail of an axonal swelling is shown in the smaller inset. e Neuritic dystrophies around plaques (asterisk) were immunopositive for synaptophysin (arrows). f1–f3 Confocal laser double immunofluorescence labeling for APP (red) and VGLUT1 (green) shows extensive colocalization (arrows) of the two markers indicating the axonal glutamatergic nature of APP-positive dystrophic neurites around plaques (asterisk). g1–g3 Double-label immunofluorescence confocal laser microscopy for APP (red) and VGAT (green) shows the existence of GABAergic axonal dystrophies (VGAT-positive and APP-negative; arrows) around amyloid plaques (asterisk). h–j Transmission electron microscopy images. h Low magnification image of an amyloid plaque (asterisk) surrounded by dystrophic neurites. i At a higher magnification, detail of the dystrophic myelinated axon circled in h; the inset shows the autophagic vesicle content of this axonal swelling and the myelin sheath. j Another representative image of a myelinated axonal swelling, filled with autophagic vesicles. The giant size of this dystrophy could be estimated by comparison with the adjacent normal myelinated axonal profiles; inset shows a detail of this axonal dystrophy. CA1–CA3 subfields of the hippocampus proper. DG dentate gyrus, sp stratum pyramidale, sl stratum lucidum. Scale bars a 250 μm, b 25 μm, c1–c3 15 μm, d 500 μm (larger inset 50 μm and smaller inset 5 μm), e 20 μm, f1–f3 and g1–g3 10 μm, h 20 μm, i 2 μm (inset 200 nm), j 2 μm (inset 500 nm)
Fig. 4 Dystrophic neurites are of axonal origin. a MAP-2 (dendritic marker) and Congo red staining in the hippocampus of 6-month-old PS1/APP mice (arrows indicate amyloid plaques). b No dystrophic neurites immunopositive for MAP-2 were seen around amyloid plaques, as illustrated here for a Congo red stained amyloid plaque (asterisk) embedded in a MAP2-positive neuropil in the radiatum layer. c1–c3 Confocal double immunofluorescence labeling for MAP-2 (red) and APP (green) revealed no colocalization of the two markers (asterisk indicates an amyloid plaque). d Strong overlapping in the location of hippocampal axonal pathways and amyloid plaques as shown here using neurofilament (NF) immunolabeling and Congo red staining. Axonal dystrophies were observed around congophilic plaques as shown in the larger inset, and a detail of an axonal swelling is shown in the smaller inset. e Neuritic dystrophies around plaques (asterisk) were immunopositive for synaptophysin (arrows). f1–f3 Confocal laser double immunofluorescence labeling for APP (red) and VGLUT1 (green) shows extensive colocalization (arrows) of the two markers indicating the axonal glutamatergic nature of APP-positive dystrophic neurites around plaques (asterisk). g1–g3 Double-label immunofluorescence confocal laser microscopy for APP (red) and VGAT (green) shows the existence of GABAergic axonal dystrophies (VGAT-positive and APP-negative; arrows) around amyloid plaques (asterisk). h–j Transmission electron microscopy images. h Low magnification image of an amyloid plaque (asterisk) surrounded by dystrophic neurites. i At a higher magnification, detail of the dystrophic myelinated axon circled in h; the inset shows the autophagic vesicle content of this axonal swelling and the myelin sheath. j Another representative image of a myelinated axonal swelling, filled with autophagic vesicles. The giant size of this dystrophy could be estimated by comparison with the adjacent normal myelinated axonal profiles; inset shows a detail of this axonal dystrophy. CA1–CA3 subfields of the hippocampus proper. DG dentate gyrus, sp stratum pyramidale, sl stratum lucidum. Scale bars a 250 μm, b 25 μm, c1–c3 15 μm, d 500 μm (larger inset 50 μm and smaller inset 5 μm), e 20 μm, f1–f3 and g1–g3 10 μm, h 20 μm, i 2 μm (inset 200 nm), j 2 μm (inset 500 nm)CC BY-NC · PubMed Central
Fig. 5 Cytoskeletal pathology in young PS1/APP hippocampus. a Quantitative Western blotting using AT8 antibody in the hippocampus of 6-month-old PS1/APP and WT mice; PS1/APP mice had significantly higher AT8 levels than to age-matched WT mice (n = 6, p < 0.05). b The presence of AT8-positive structures around plaques (asterisk) was observed from 4 months of age. c1–c4 and d1–d4. Double-label immunofluorescence confocal laser microscopy of APP (green) and AT8 (red) in 6-month-old transgenic mice showing the presence of phospho-tau in some APP-positive dystrophic neurites. e Immunohistochemistry for cofilin revealed the presence of actin–cofilin rods around plaques (asterisk) from 4 months of age. A higher magnification detail of a rod is shown in the inset. f1–f3 Confocal laser microscopy with double APP/cofilin labeling revealed the presence of cofilin within some APP-positive neurites. g Quantitative Western blotting for heavy chain kinesin-1 and dynein in 6-month-old PS1/APP and WT mice hippocampus. PS1/APP mice were found to have significantly lower kinesin-1 and dynein levels than age-matched WT mice (n = 8, p < 0.05). Scale bars b 100 μm, c1–c3 5 μm, c4 2.5 μm, d1–d3 7.5 μm, d4 2.5 μm, e 50 μm (inset 7 μm), f1–f3 7.5 μm
Fig. 5 Cytoskeletal pathology in young PS1/APP hippocampus. a Quantitative Western blotting using AT8 antibody in the hippocampus of 6-month-old PS1/APP and WT mice; PS1/APP mice had significantly higher AT8 levels than to age-matched WT mice (n = 6, p < 0.05). b The presence of AT8-positive structures around plaques (asterisk) was observed from 4 months of age. c1–c4 and d1–d4. Double-label immunofluorescence confocal laser microscopy of APP (green) and AT8 (red) in 6-month-old transgenic mice showing the presence of phospho-tau in some APP-positive dystrophic neurites. e Immunohistochemistry for cofilin revealed the presence of actin–cofilin rods around plaques (asterisk) from 4 months of age. A higher magnification detail of a rod is shown in the inset. f1–f3 Confocal laser microscopy with double APP/cofilin labeling revealed the presence of cofilin within some APP-positive neurites. g Quantitative Western blotting for heavy chain kinesin-1 and dynein in 6-month-old PS1/APP and WT mice hippocampus. PS1/APP mice were found to have significantly lower kinesin-1 and dynein levels than age-matched WT mice (n = 8, p < 0.05). Scale bars b 100 μm, c1–c3 5 μm, c4 2.5 μm, d1–d3 7.5 μm, d4 2.5 μm, e 50 μm (inset 7 μm), f1–f3 7.5 μmCC BY-NC · PubMed Central
Fig. 6 Autophagy pathology correlates with aberrant presynaptic terminals. a–e Transmission electron microscopy images of aberrant axon terminals (outlined with white lines) containing autophagic vesicles and making asymmetric contact with normal postsynaptic elements (asterisks the postsynaptic densities are indicated with black arrows). a and b Severely disrupted presynaptic terminals (white lines) containing numerous autophagic vesicles and apparently no synaptic vesicles. A presynaptic element (outlined with black lines) that contains one autophagy vesicle (indicated with white arrow), near to the active zone is shown in b. c and d Presynaptic terminals in a probable initial stage of the dystrophy development, were characterized by the accumulation of relatively few autophagic vesicles (white arrows) and many synaptic vesicles. e Presynaptic terminal showing a putative phagophore (PA) engulfing synaptic-like vesicles, as well as an autophagosome containing mitochondria (open arrow) and few autophagic vesicles containing degraded material (white arrows). f Quantitative immunoblot analyses of the LC3-II form in microsomes and synaptosomes from 6-month-old PS1/APP and WT mice. LC3-II accumulated in both microsomal and synaptosomal fractions of WT and PS1/APP hippocampus, though a predominant localization was found in the microsomal fraction. The levels of LC3-II in WT synaptosomes were extremely low, as compared with microsomes (please note the different scale bars). Although in PS1/APP most LC3-II was also present in microsomes, the relative accumulation was more patent in synaptosomes (as compared with WT). The relative abundance of LC3-II in each fraction was normalized by the values for WT microsomal fractions. ATPsynthase and β-actin were used as markers of purity in the isolation procedure and protein loading, respectively. m mitochondria. Scale bars a 1 μm, b–e 500 nm
Fig. 6 Autophagy pathology correlates with aberrant presynaptic terminals. a–e Transmission electron microscopy images of aberrant axon terminals (outlined with white lines) containing autophagic vesicles and making asymmetric contact with normal postsynaptic elements (asterisks the postsynaptic densities are indicated with black arrows). a and b Severely disrupted presynaptic terminals (white lines) containing numerous autophagic vesicles and apparently no synaptic vesicles. A presynaptic element (outlined with black lines) that contains one autophagy vesicle (indicated with white arrow), near to the active zone is shown in b. c and d Presynaptic terminals in a probable initial stage of the dystrophy development, were characterized by the accumulation of relatively few autophagic vesicles (white arrows) and many synaptic vesicles. e Presynaptic terminal showing a putative phagophore (PA) engulfing synaptic-like vesicles, as well as an autophagosome containing mitochondria (open arrow) and few autophagic vesicles containing degraded material (white arrows). f Quantitative immunoblot analyses of the LC3-II form in microsomes and synaptosomes from 6-month-old PS1/APP and WT mice. LC3-II accumulated in both microsomal and synaptosomal fractions of WT and PS1/APP hippocampus, though a predominant localization was found in the microsomal fraction. The levels of LC3-II in WT synaptosomes were extremely low, as compared with microsomes (please note the different scale bars). Although in PS1/APP most LC3-II was also present in microsomes, the relative accumulation was more patent in synaptosomes (as compared with WT). The relative abundance of LC3-II in each fraction was normalized by the values for WT microsomal fractions. ATPsynthase and β-actin were used as markers of purity in the isolation procedure and protein loading, respectively. m mitochondria. Scale bars a 1 μm, b–e 500 nmCC BY-NC · PubMed Central
Fig. 7 Monomeric Aβ accumulates in isolated synaptosomes whereas Aβ oligomers are present in the plaque periphery and microsomes. a The Aβ content were analyzed by 6E10 immunoprecipitation and Western blots (16%-Tris-Tricine-SDS-PAGE) in synaptosomal and microsomal fractions from 6-month-old WT and PS1/APP mice (a1) or by 82E1 Western blots after urea-SDS-PAGE (16%) in PS1/APP synaptosomal fractions (a2). As shown, the monomeric Aβ was predominantly enriched in the synaptosomal fractions (a1). From the different Aβ peptides, the Aβ42 was the predominant form found in synaptosomes (a2). b Oligomeric Aβ peptides were localized at the periphery of the plaques by immunohistochemistry with the A11 antibody. Inset shows a higher magnification of an immunostained amyloid plaque. c The presence of oligomeric Aβ in extracellular soluble fractions (S1), synaptosomes and microsomes was assessed by immunoprecipitation experiments, using the A11 antibody, and Western blots (6E10) using 12%-Tris-Glycine-SDS-PAGE. In agreement with a putative plaque origin, Aβ oligomers (57, 90 and 96 kDa) were identified in S1 fractions. d Representative Western blot of WT and PS1/APP microsomal fractions using the mAb 82E1. As shown, Aβ oligomers (ranging Mr 30–60 kDa) were clearly identified using this antibody. CA1–CA3 subfields of the hippocampus proper, DG dentate gyrus. Scale bars b 250 μm (inset 25 μm)
Fig. 7 Monomeric Aβ accumulates in isolated synaptosomes whereas Aβ oligomers are present in the plaque periphery and microsomes. a The Aβ content were analyzed by 6E10 immunoprecipitation and Western blots (16%-Tris-Tricine-SDS-PAGE) in synaptosomal and microsomal fractions from 6-month-old WT and PS1/APP mice (a1) or by 82E1 Western blots after urea-SDS-PAGE (16%) in PS1/APP synaptosomal fractions (a2). As shown, the monomeric Aβ was predominantly enriched in the synaptosomal fractions (a1). From the different Aβ peptides, the Aβ42 was the predominant form found in synaptosomes (a2). b Oligomeric Aβ peptides were localized at the periphery of the plaques by immunohistochemistry with the A11 antibody. Inset shows a higher magnification of an immunostained amyloid plaque. c The presence of oligomeric Aβ in extracellular soluble fractions (S1), synaptosomes and microsomes was assessed by immunoprecipitation experiments, using the A11 antibody, and Western blots (6E10) using 12%-Tris-Glycine-SDS-PAGE. In agreement with a putative plaque origin, Aβ oligomers (57, 90 and 96 kDa) were identified in S1 fractions. d Representative Western blot of WT and PS1/APP microsomal fractions using the mAb 82E1. As shown, Aβ oligomers (ranging Mr 30–60 kDa) were clearly identified using this antibody. CA1–CA3 subfields of the hippocampus proper, DG dentate gyrus. Scale bars b 250 μm (inset 25 μm)CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 222

Metadata

Authors
Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., Davila, J. C., Garcia-Verdugo, J. M., Jimenez, A. J., Vitorica, J., & Gutierrez, A.
Affiliations
  • Universidad de Málaga (ES)
  • Consejo Superior de Investigaciones Científicas (ES)
Venue
Acta Neuropathologica
Published
2011-10-22
Volume
123
Issue
1
Pages
53-70
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2001428953
Cited by
222
References
70
Citations by year
2026: 10 · 2025: 17 · 2024: 12 · 2023: 19 · 2022: 20 · 2021: 17 · 2020: 14 · 2019: 21 · 2018: 20 · 2017: 15 · 2016: 12 · 2015: 9 · 2014: 16 · 2013: 14 · 2012: 5
FWCI
7.63
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Acta Neuropathologica (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • idUS (Universidad de Sevilla) (publishedVersion, cc-by-nc-nd)
  • Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, public-domain)
  • Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by-nc)
  • Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
Funders
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
  • Instituto de Salud Carlos III
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, autophagic vesicles, autophagy, axonal dystrophy, neuritic plaques, amyloid-beta oligomers, presynaptic terminals, synaptic dysfunction, LC3, tau phosphorylation, kinesin-1, dynein motor, axonal transport, hippocampus, preclinical Alzheimer's disease, dystrophic neurites
MeSH terms
Alzheimer Disease, Animals, Autophagy, Axons, Disease Models, Animal, Hippocampus, Mice, Transgenic, Neurons, Microscopy, Immunoelectron, Neurites, Amyloid beta-Protein Precursor, Presynaptic Terminals, Cytoplasmic Vesicles, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus. https://app.cochat.ai/papers/10.1007/s00401-011-0896-x
The paper
Sanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., Davila, J. C., Garcia-Verdugo, J. M., Jimenez, A. J., Vitorica, J., & Gutierrez, A. (2012). Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus. Acta Neuropathologica. https://doi.org/10.1007/s00401-011-0896-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.